The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Order-disorder transitions govern kinetic cooperativity and allostery of monomeric human glucokinase
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, crosspeaks from five additional Ile residues within the small domain were invisible on the NMR timescale, demonstrating that this region experiences millisecond conformational dynamics.”
From Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease (2020) · cites this paper as [30]
In the citing paper
“Two-dimensional (2D) 1 H-13 C heteronuclear multiple quantum coherence (HMQC) investigations of 13 C-Ile methyl group labeled GCK confirm that the 151-180 loop is disordered in the unliganded state (30).”
From Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease (2020) · cites this paper as [30]
In the citing paper
“Past investigations have suggested that a-type activation results from substitutions that shift the conformational ensemble of the unliganded enzyme toward a single, glucose-bound-like state (30,31).”
From Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease (2020) · cites this paper as [30]
In the citing paper
“The first is a pre-existing equilibrium between unliganded GCK conformations that interconvert on the same timescale as turnover (30,36).”
From Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease (2020) · cites this paper as [30]
In the citing paper
“This finding is consistent with the results of NMR studies on GCK containing 13 C-Ile probes at loop residues 159 and 163 (30).”
From Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease (2020) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intrinsically unstructured proteins and their functions
Dyson, H. J., & Wright, P. E. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1589 · Cited by 3,871
BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis
Danial, N. N., Gramm, C. F., Scorrano, L., Zhang, C.-Y., Krauss, S., Ranger, A. M., Robert Datta, S., Greenberg, M. E., Licklider, L. J., Lowell, B. B., et al. (2003) · Nature · doi:10.1038/nature01825 · Cited by 705
Diabetes mellitus and genetically programmed defects in β-cell function
Bell, G. I., & Polonsky, K. S. (2001) · Nature · doi:10.1038/414788a · Cited by 475
Research works printed but not linked: 57
- Cornish-Bowden A, Cárdenas ML (2004) Glucokinase: a monomeric enzyme with positive cooperativity. In: Matschinsky FM, Magnuson MA, editors. Glucokinase and glycemic disease: from basics to novel therapeutics. Frontiers in Diabetes. Basel: Karger pp. 125–134. · doi:10.1159/000079011
- FM Matschinsky, 1990, Glucokinase as glucose sensor and metabolic signal generator in pancreatic β-cells and hepatocytes, Diabetes, 39, 647, 10.2337/diab.39.6.647 · DOI · Paper page
- MD Meglasson, 1984, New perspectives in pancreatic islet glucokinase, Am J Physiol Endocrinol Metab, 246, E1, 10.1152/ajpendo.1984.246.1.E1 · DOI · Paper page
- H Al-Hasani, 2003, Two birds with one stone: novel glucokinase activator stimulates glucose-induced pancreatic insulin secretion and augments hepatic glucose metabolism, Mol Interv, 3, 367, 10.1124/mi.3.7.367 · DOI
- N Vionnet, 1992, Nonsense mutation in the glucokinase gene causes early onset non-insulin-dependent diabetes mellitus, Nature, 356, 721, 10.1038/356721a0 · DOI · Paper page
- B Glaser, 1998, Familial hyperinsulinism caused by an activating glucokinase mutation, N Engl J Med, 338, 226, 10.1056/NEJM199801223380404 · DOI · Paper page
- KK Osbak, 2009, Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia, Hum Mutat, 30, 1512, 10.1002/humu.21110 · DOI · Paper page
- AL Cuesta-Muñoz, 2004, Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation, Diabetes, 53, 2164, 10.2337/diabetes.53.8.2164 · DOI · Paper page
- B Glaser, 1998, Familial hyperinsulinism caused by an activating glucokinase mutation, N Engl J Med, 338, 226, 10.1056/NEJM199801223380404 · DOI · Paper page
- AL Golyn, 2003, Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy, Hum Mutat, 22, 353, 10.1002/humu.10277 · DOI · Paper page
- B Glaser, 2000, Genetics of neonatal hyperinsulinism, Arch Dis Child, 82, 79, 10.1136/fn.82.2.F79 · DOI · Paper page
- T Meissner, 2009, Diagnostic difficulties in glucokinase hyperinsulinism, Horm Metab Res, 41, 320, 10.1055/s-0028-1102922 · DOI
- HBT Christesen, 2008, Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation, Eur J Endocrinol, 159, 27, 10.1530/EJE-08-0203 · DOI
- M Wabitsch, 2007, Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy, Diabet Med, 24, 1393, 10.1111/j.1464-5491.2007.02285.x · DOI
- AL Gloyn, 2003, Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations, Diabetes, 52, 2433, 10.2337/diabetes.52.9.2433 · DOI · Paper page
- EA Davis, 1999, Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis, Diabetologia, 42, 1175, 10.1007/s001250051289 · DOI · Paper page
- Gloyn AL, Odili S, Buettger C, Njølstad PR, Shiota C, <etal>et al</etal>.. (2004) Glucokinase and the regulation of blood sugar. A mathematical model predicts the threshold for glucose stimulated insulin release for GCK gene mutations that cause hyper- and hypoglycemia. In: Matschinsky FM, Magnuson MA, editors. Glucokinase and glycemic disease: from basics to novel therapeutics. Frontiers in Diabetes. Basel: Karger pp. 92–109. · DOI
- P Pal, 2009, Activating mutations in the human glucokinase gene revealed by genetic selection, Biochemistry, 48, 814, 10.1021/bi802142q · doi:10.1021/bi802142q
- J Grimsby, 2003, Allosteric activators of glucokinase: potential role in diabetes therapy, Science, 301, 370, 10.1126/science.1084073 · DOI · Paper page
- FM Matschinsky, 2009, Assessing the potential of glucokinase activators in diabetes therapy, Nat Rev Drug Discov, 8, 399, 10.1038/nrd2850 · DOI · Paper page
- J Wyman, 1963, Allosteric effects in hemoglobin, Cold Spring Harb Symp Quant Biol, 28, 483, 10.1101/SQB.1963.028.01.064 · doi:10.1101/sqb.1963.028.01.064
- ER Kantrowitz, 1988, Escherichia coli aspartate transcarbamylase: the relation between structure and function, Science, 241, 669, 10.1126/science.3041592 · doi:10.1126/science.3041592
- J Monod, 1965, On the nature of allosteric transitions: a plausible model, J Mol Biol, 12, 88, 10.1016/S0022-2836(65)80285-6 · DOI · Paper page
- DE Koshland Jr, 1966, Comparison of experimental binding data and theoretical models in proteins containing subunits, Biochemistry, 5, 365, 10.1021/bi00865a047 · DOI · Paper page
- GR Ainslie Jr, 1972, Transients and cooperativity. A slow transition model for relating transients and cooperative kinetics of enzymes, J Biol Chem, 247, 7088
- J Richard, 1974, Regulatory behavior of monomeric enzymes. 1. The mnemonical enzyme concept, Eur J Biochem, 49, 195, 10.1111/j.1432-1033.1974.tb03825.x · doi:10.1111/j.1432-1033.1974.tb03825.x
- K Kamata, 2004, Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase, Structure, 12, 429, 10.1016/j.str.2004.02.005 · DOI · Paper page
- S Liu, 2012, Insights into mechanism of glucokinase activation: observation of multiple distinct protein conformations, J Biol Chem, 287, 13598, 10.1074/jbc.M111.274126 · DOI
- KE Neet, 1990, Observation of a kinetic slow transition in monomeric glucokinase, Biochemistry, 29, 770, 10.1021/bi00455a026 · doi:10.1021/bi00455a026
- SX Lin, 1990, Demonstration of a slow conformational change in liver glucokinase by fluorescence spectroscopy, J Biol Chem, 265, 9670, 10.1016/S0021-9258(19)38722-8 · DOI · Paper page
- M Larion, 2010, Direct evidence of conformational heterogeneity in human pancreatic glucokinase from high-resolution nuclear magnetic resonance, Biochemistry, 49, 7969, 10.1021/bi101098f · DOI
- B Zelent, 2012, Thermal stability of glucokinase (GK) as influenced by the substrate glucose, an allosteric glucokinase activator drug (GKA) and the osmolytes glycerol and urea, Biochimica et Biophysica Acta, 1824, 769, 10.1016/j.bbapap.2012.03.003 · DOI
- P Petit, 2011, The active conformation of human glucokinase is not altered by allosteric activators, Acta Cryst, D67, 929
- Q Liu, 2011, Crystal structure of E339K mutated human glucokinase reveals changes in the ATP binding site, FEBS Lett, 585, 1175, 10.1016/j.febslet.2011.03.026 · doi:10.1016/j.febslet.2011.03.026
- GR Bebernitz, 2009, Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes, J Med Chem, 52, 6142, 10.1021/jm900839k · DOI
- T Nishimura, 2009, Identification of novel and potent 2-amino benzamide derivatives as allosteric glucokinase activators, Bioorg Med Chem Lett, 19, 1357, 10.1016/j.bmcl.2009.01.053 · DOI · Paper page
- M Mitsuya, 2009, Discovery of novel 3,6-disubstituted 2-pyridinecarboxamide derivatives as GK activators, Bioorg Med Chem Lett, 19, 2718, 10.1016/j.bmcl.2009.03.137 · doi:10.1016/j.bmcl.2009.03.137
- V Tugarinov, 2006, Isotope labeling strategies for the study of high-molecular-weight proteins by solution NMR spectroscopy, Nat Protoc, 1, 749, 10.1038/nprot.2006.101 · DOI · Paper page
- R Sprangers, 2007, Quantitative dynamics and binding studies of the 20S proteasome by NMR, Nature, 445, 618, 10.1038/nature05512 · DOI · Paper page
- DC Muchmore, 1989, Expression and nitrogen-15 labeling of proteins for nitrogen-15 Nuclear Magnetic Resonance, Method Enzymol, 177, 44, 10.1016/0076-6879(89)77005-1 · DOI · Paper page
- DS Wishart, 1994, The 13C Chemical-Shift Index: a simple method for the identification of protein secondary structure using 13C chemical-shift data, J Biomol NMR, 4, 171, 10.1007/BF00175245 · DOI · Paper page
- DF Hansen, 2010, Determination of isoleucine side-chain conformations in ground and excited states of proteins from chemical shifts, J Am Chem Soc, 133, 8272
- M Larion, 2009, 23-residue C-terminal α-helix governs kinetic cooperativity in monomeric human glucokinase, Biochemistry, 48, 6157, 10.1021/bi9007534 · DOI
- VV Heredia, 2006, Glucose-induced conformational changes in glucokinase mediate allosteric regulation: transient kinetic analysis, Biochemistry, 45, 7553, 10.1021/bi060253q · DOI
- YB Kim, 2007, A pre-steady state analysis of ligand binding to human glucokinase: evidence for a preexisting equilibrium, Biochemistry, 46, 1423, 10.1021/bi0617308 · DOI
- M Antoine, 2009, Binding kinetics of glucose and allosteric activators to human glucokinase reveal multiple conformational states, Biochemistry, 48, 5466, 10.1021/bi900374c · DOI
- M Larion, 2010, Global fit analysis of glucose binding curves reveals a minimal model for kinetic cooperativity in human glucokinase, Biochemistry, 49, 8902, 10.1021/bi1008672 · DOI · Paper page
- C Frieden, 1970, Kinetic aspects of regulation of metabolic processes. The hysteretic enzyme concept, J Biol Chem, 245, 5788, 10.1016/S0021-9258(18)62721-8 · DOI · Paper page
- NS Bogatyreva, 2009, KineticDB: a database of protein folding kinetics, Nucl Acids Res, 37, D342, 10.1093/nar/gkn696 · doi:10.1093/nar/gkn696
- B Zambelli, 2012, Insights in the (un)structural organization of Bacillus pasteurii UreG, an intrinsically disordered GTPase enzyme, Mol BioSyst, 8, 220, 10.1039/C1MB05227F · DOI
- S Baltrusch, 2001, Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library: identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner, J Biol Chem, 276, 43915, 10.1074/jbc.M105470200 · DOI
- van Schaftingen EF, Veiga da Cunha M (2004) Discovery and role of glucokinase regulatory protein. In: Matschinsky FM, Magnuson MA, editors. Glucokinase and glycemic disease: from basics to novel therapeutics. Frontiers in Diabetes. Basel: Karger. pp 125–134. · DOI
- MA Rizzo, 2003, Regulation of β-cell glucokinase by S-nitrosylation and association with nitric oxide synthase, J Cell Biol, 161, 243, 10.1083/jcb.200301063 · DOI
- L Bjorkhaug, 2007, Allosteric activation of human glucokinase by free polyubiquitin chains and its ubiquitin-dependent cotranslational proteasomal degradation, J Biol Chem, 282, 22757, 10.1074/jbc.M700517200 · DOI
- F Delaglio, 1995, NMRPipe: a multidimensional spectral processing system based on UNIX pipes, J Biomol NMR, 6, 277, 10.1007/BF00197809 · DOI · Paper page
- WF Vranken, 2005, The CCPN data model for NMR spectroscopy: development of a software pipeline, Proteins, 59, 687, 10.1002/prot.20449 · DOI · Paper page
- JA Marsh, 2006, Sensitivity of secondary structure propensities to sequence differences between α- and γ-synuclein: implications for fibrillation, Proteins, 15, 2795, 10.1110/ps.062465306 · DOI · Paper page
Cited by
A comprehensive map of human glucokinase variant activity
Gersing, S., Cagiada, M., Gebbia, M., Gjesing, A. P., Coté, A. G., Seesankar, G., Li, R., Tabet, D., Weile, J., Stein, A., et al. (2023) · Genome Biology · doi:10.1186/s13059-023-02935-8 · Cited by 55
Characterizing glucokinase variant mechanisms using a multiplexed abundance assay
Gersing, S., Schulze, T. K., Cagiada, M., Stein, A., Roth, F. P., Lindorff-Larsen, K., & Hartmann-Petersen, R. (2024) · Genome Biology · doi:10.1186/s13059-024-03238-2 · Cited by 23
Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease
Sternisha, S. M., Whittington, A. C., Martinez Fiesco, J. A., Porter, C., McCray, M. M., Logan, T., Olivieri, C., Veglia, G., Steinbach, P. J., & Miller, B. G. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2019.12.036 · Cited by 17
Self-citation
Metadata
- Authors
- Larion, M., Salinas, R. K., Bruschweiler-Li, L., Miller, B. G., & Brüschweiler, R.
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-18
- Volume
- 10
- Issue
- 12
- Pages
- e1001452
- ISSN
- 1545-7885
- Cited by
- 66
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Order-disorder transitions govern kinetic cooperativity and allostery of monomeric human glucokinase. https://app.cochat.ai/papers/10.1371/journal.pbio.1001452
- The paper
- Larion, M., Salinas, R. K., Bruschweiler-Li, L., Miller, B. G., & Brüschweiler, R. (2012). Order-disorder transitions govern kinetic cooperativity and allostery of monomeric human glucokinase. PLoS Biology. https://doi.org/10.1371/journal.pbio.1001452
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.